Rock Creek Pharmaceuticals Inc. (fka RCPIQ)

[haysaw]

Thanks for your response. Why couldn't they potentially get any of these expedited approvals by targeting inflammation in general? Keep in mind, anatabine is not being touted as a cure. Consider this from the wikipedia FDA Fast Track Development Program page:

If there are existing therapies, a fast track eligible drug must show some advantage over available treatment, such as:

Showing superior effectiveness
Avoiding serious side effects of an available treatment
Improving the diagnosis of a serious disease where early diagnosis results in an improved outcome
Decreasing a clinically significant toxicity of an available treatment
Addressing an expected public health need